Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Mar;21(3):736-742.
doi: 10.1038/s41436-018-0138-x. Epub 2018 Sep 21.

Autozygome and high throughput confirmation of disease genes candidacy

Affiliations

Autozygome and high throughput confirmation of disease genes candidacy

Sateesh Maddirevula et al. Genet Med. 2019 Mar.

Abstract

Purpose: Establishing links between Mendelian phenotypes and genes enables the proper interpretation of variants therein. Autozygome, a rich source of homozygous variants, has been successfully utilized for the high throughput identification of novel autosomal recessive disease genes. Here, we highlight the utility of the autozygome for the high throughput confirmation of previously published tentative links to diseases.

Methods: Autozygome and exome analysis of patients with suspected Mendelian phenotypes. All variants were classified according to the American College of Medical Genetics and Genomics guidelines.

Results: We highlight 30 published candidate genes (ACTL6B, ADAM22, AGTPBP1, APC, C12orf4, C3orf17 (NEPRO), CENPF, CNPY3, COL27A1, DMBX1, FUT8, GOLGA2, KIAA0556, LENG8, MCIDAS, MTMR9, MYH11, QRSL1, RUBCN, SLC25A42, SLC9A1, TBXT, TFG, THUMPD1, TRAF3IP2, UFC1, UFM1, WDR81, XRCC2, ZAK) in which we identified homozygous likely deleterious variants in patients with compatible phenotypes. We also identified homozygous likely deleterious variants in 18 published candidate genes (ABCA2, ARL6IP1, ATP8A2, CDK9, CNKSR1, DGAT1, DMXL2, GEMIN4, HCN2, HCRT, MYO9A, PARS2, PLOD3, PREPL, SCLT1, STX3, TXNRD2, WIPI2) although the associated phenotypes are sufficiently different from the original reports that they represent phenotypic expansion or potentially distinct allelic disorders.

Conclusions: Our results should facilitate the timely relabeling of these candidate disease genes in relevant databases to improve the yield of clinical genomic sequencing.

Keywords: ACMG guidelines; candidate genes; variant interpretation.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Fig. 1
Fig. 1
Representative images of cases with class 1 phenotypes. a Panel of clinical images of the proband with APC-related Cenani–Lenz syndrome showing the classic bony syndactyly with loss of the normal configuration of the phalanges. b Brain magnetic resonance image (MRI) of the proband with pathogenic variant in ACTL6B showing agenesis of corpus callosum and mild ventricular dilatation (2.70 cm). c Typical skeletal findings in the proband with XRCC2-related Fanconi anemia showing hypoplastic thumbs and dysplastic hips. d Brain MRI image showing thin but complete corpus callosum in the proband with GOLGA2 pathogenic variant. e Clinical images of the proband with Steel syndrome (pathogenic variant in COL27A1) showing characteristic facial and skeletal appearance (elongated face with severe scoliosis). f Facial photograph and MRI brain of the proband with pathogenic variant in CENPF showing small head, relatively large ears, epicanthal folds, blue-tinged sclerae, prominent nose, thin upper lip, and small chin. MRI revealed reduced white matter volume and marginal pachygyria. g Brain MRI image showing mild molar tooth sign in the proband with KIAA0556 pathogenic variant. h Facial photographs of proband with FUT8 pathogenic variant showing coarse face with synophrys, hypertelorism, sparse eye-lashes, low set ears, thick inverted V-shaped lips.
Fig. 2
Fig. 2
Representative images of cases with class 2 and 3 phenotypes. a Clinical images of the proband with TXNRD2 pathogenic variant showing dysmorphic facies and a large umbilical hernia. b The two siblings with SCLT1 pathogenic variant showing absence of the anterior lobe of pituitary gland with the evidence of ectopia of the posterior pituitary gland and thalamic hamartoma. c Three families are with CDK9-related CHARGE-like phenotype showing cerebellar atrophy, unilateral choanal atresia, and dysplastic atrophic kidney. d Brain magnetic resonance image (MRI) of proband with pathogenic variant in PARS2 showing severe cerebral volume loss indicating severe brain atrophy, thinning of the corpus callosum, and severe cerebral volume loss in the supratentorial and infratentorial area. e Clinical images of the proband with PLOD3 pathogenic variant showing dysmorphic facies (prominent forehead, short and flat nose, ptosis with compensatory arching of eyebrows, posteriorly rotated low set ears) and hand contractures. f Facial features and MRI images of proband with DMXL2 pathogenic variant represent long face, high forehead, short philtrum, low set ears, and moderate degree of cerebral and brainstem atrophy. g Brain MRI image showing small atrophic cerebellum with prominence of the posterior fossa cerebrospinal fluid (CSF) spaces in the proband with GEMIN4 pathogenic variant. h Facial pictures of index (16DG0071) subject with ABCA2 showing apparent lack of gross dysmorphism.

Similar articles

  • Lessons Learned from Large-Scale, First-Tier Clinical Exome Sequencing in a Highly Consanguineous Population.
    Monies D, Abouelhoda M, Assoum M, Moghrabi N, Rafiullah R, Almontashiri N, Alowain M, Alzaidan H, Alsayed M, Subhani S, Cupler E, Faden M, Alhashem A, Qari A, Chedrawi A, Aldhalaan H, Kurdi W, Khan S, Rahbeeni Z, Alotaibi M, Goljan E, Elbardisy H, ElKalioby M, Shah Z, Alruwaili H, Jaafar A, Albar R, Akilan A, Tayeb H, Tahir A, Fawzy M, Nasr M, Makki S, Alfaifi A, Akleh H, Yamani S, Bubshait D, Mahnashi M, Basha T, Alsagheir A, Abu Khaled M, Alsaleem K, Almugbel M, Badawi M, Bashiri F, Bohlega S, Sulaiman R, Tous E, Ahmed S, Algoufi T, Al-Mousa H, Alaki E, Alhumaidi S, Alghamdi H, Alghamdi M, Sahly A, Nahrir S, Al-Ahmari A, Alkuraya H, Almehaidib A, Abanemai M, Alsohaibaini F, Alsaud B, Arnaout R, Abdel-Salam GMH, Aldhekri H, AlKhater S, Alqadi K, Alsabban E, Alshareef T, Awartani K, Banjar H, Alsahan N, Abosoudah I, Alashwal A, Aldekhail W, Alhajjar S, Al-Mayouf S, Alsemari A, Alshuaibi W, Altala S, Altalhi A, Baz S, Hamad M, Abalkhail T, Alenazi B, Alkaff A, Almohareb F, Al Mutairi F, Alsaleh M, Alsonbul A, Alzelaye S, Bahzad S, Manee AB, Jarrad O, Meriki N, Albeirouti B, Alqasmi A, AlBalwi M, Makhseed N, Hassan S, Salih I, Salih MA, Shaheen M, Sermin S, Shahrukh S, Hashmi S, Sha… See abstract for full author list ➔ Monies D, et al. Am J Hum Genet. 2019 Jun 6;104(6):1182-1201. doi: 10.1016/j.ajhg.2019.04.011. Epub 2019 May 23. Am J Hum Genet. 2019. PMID: 31130284 Free PMC article.
  • Performance of ACMG-AMP Variant-Interpretation Guidelines among Nine Laboratories in the Clinical Sequencing Exploratory Research Consortium.
    Amendola LM, Jarvik GP, Leo MC, McLaughlin HM, Akkari Y, Amaral MD, Berg JS, Biswas S, Bowling KM, Conlin LK, Cooper GM, Dorschner MO, Dulik MC, Ghazani AA, Ghosh R, Green RC, Hart R, Horton C, Johnston JJ, Lebo MS, Milosavljevic A, Ou J, Pak CM, Patel RY, Punj S, Richards CS, Salama J, Strande NT, Yang Y, Plon SE, Biesecker LG, Rehm HL. Amendola LM, et al. Am J Hum Genet. 2016 Jun 2;98(6):1067-1076. doi: 10.1016/j.ajhg.2016.03.024. Epub 2016 May 12. Am J Hum Genet. 2016. PMID: 27181684 Free PMC article.
  • Accelerating matchmaking of novel dysmorphology syndromes through clinical and genomic characterization of a large cohort.
    Shaheen R, Patel N, Shamseldin H, Alzahrani F, Al-Yamany R, ALMoisheer A, Ewida N, Anazi S, Alnemer M, Elsheikh M, Alfaleh K, Alshammari M, Alhashem A, Alangari AA, Salih MA, Kircher M, Daza RM, Ibrahim N, Wakil SM, Alaqeel A, Altowaijri I, Shendure J, Al-Habib A, Faqieh E, Alkuraya FS. Shaheen R, et al. Genet Med. 2016 Jul;18(7):686-95. doi: 10.1038/gim.2015.147. Epub 2015 Dec 3. Genet Med. 2016. PMID: 26633546
  • A retrospective review of multiple findings in diagnostic exome sequencing: half are distinct and half are overlapping diagnoses.
    Smith ED, Blanco K, Sajan SA, Hunter JM, Shinde DN, Wayburn B, Rossi M, Huang J, Stevens CA, Muss C, Alcaraz W, Hagman KDF, Tang S, Radtke K. Smith ED, et al. Genet Med. 2019 Oct;21(10):2199-2207. doi: 10.1038/s41436-019-0477-2. Epub 2019 Mar 21. Genet Med. 2019. PMID: 30894705 Free PMC article. Review.
  • Navigating the nuances of clinical sequence variant interpretation in Mendelian disease.
    Strande NT, Brnich SE, Roman TS, Berg JS. Strande NT, et al. Genet Med. 2018 Sep;20(9):918-926. doi: 10.1038/s41436-018-0100-y. Epub 2018 Jul 10. Genet Med. 2018. PMID: 29988079 Free PMC article. Review.

Cited by

References

    1. Alkuraya FS. Discovery of mutations for Mendelian disorders. Hum Genet. 2016;135:615–623. doi: 10.1007/s00439-016-1664-8. - DOI - PubMed
    1. Wright CF, FitzPatrick DR, Firth HV. Paediatric genomics: diagnosing rare disease in children. Nat Rev Genet. 2018;19:253–268. doi: 10.1038/nrg.2017.116. - DOI - PubMed
    1. Wright Caroline F, McRae Jeremy F, Clayton Stephen, Gallone Giuseppe, Aitken Stuart, FitzGerald Tomas W, Jones Philip, Prigmore Elena, Rajan Diana, Lord Jenny, Sifrim Alejandro, Kelsell Rosemary, Parker Michael J, Barrett Jeffrey C, Hurles Matthew E, FitzPatrick David R, Firth Helen V. Making new genetic diagnoses with old data: iterative reanalysis and reporting from genome-wide data in 1,133 families with developmental disorders. Genetics in Medicine. 2018;20(10):1216–1223. doi: 10.1038/gim.2017.246. - DOI - PMC - PubMed
    1. Nambot S, Thevenon J, Kuentz P, et al. Clinical whole-exome sequencing for the diagnosis of rare disorders with congenital anomalies and/or intellectual disability: substantial interest of prospective annual reanalysis. Genet Med. 2017;20:645–654. doi: 10.1038/gim.2017.162. - DOI - PubMed
    1. Eldomery MK, Coban-Akdemir Z, Harel T, et al. Lessons learned from additional research analyses of unsolved clinical exome cases. Genome Med. 2017;9:26. doi: 10.1186/s13073-017-0412-6. - DOI - PMC - PubMed

Publication types

MeSH terms